Streetwise Articles


Phase 2 Study Begins for German Biopharma's Cancer Drug Candidate

Research Report
  ()
A LifeSci Capital report discussed two current trials in which this therapeutic is being evaluated. read more >

Biotech's Flu Vaccine Shows 'Superiority to Market Leader' in Data

Research Report
  ()
Study findings that differentiate this product from competitors were reviewed in a Ladenburg Thalmann research report. read more >
News Update

Healthcare Solutions Provider to Acquire Medical Software Firm

News Update
  ()
The merger will allow the Canadian company to expand its online technology platform. read more >

Target Raised on Nutraceutical Firm After It Inks 'Marquee Partnership'

Research Report
  ()
The agreement terms and benefits of the partnership to this pharmaceutical company were relayed in an H.C. Wainwright & Co. report. read more >

Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic

Research Report
  ()
The background and justification for the deal was covered in an H.C. Wainwright & Co. report. read more >

Potential Tenbagger Biopharma Displays 'Strong Start to New Year'

Research Report
  ()
A ROTH Capital Partners report discussed the recent trial launch and provided upcoming catalysts for the stock. read more >

Texas-Based Biopharma Gets PDUFA Date for Lead Orphan Disease Asset

Research Report
  ()
An H.C. Wainwright & Co. report covered the potential timeline to market and subsequent estimated revenue for this therapeutic, which addresses a rare disorder in collagen production. read more >

Coverage Initiated on Pharma 'Leveraging Large Markets with Differentiated Products'

Research Report
  ()
A Ladenburg Thalmann report outlined the investment thesis for this Colorado-based life sciences firm. read more >

Therapeutics Developer Secures Patents, Continues Phase 3 Trial Planning

Research Report
  ()
An H.C. Wainwright & Co. report provided an update on the Q3/18 activities and achievements of this company targeting NASH. read more >

Coverage Initiated on Vaccine Developer with 'Transformational' Data Expected

Research Report
  ()
A Ladenburg Thalmann report discussed this biotech's late-stage clinical assets in RSV and influenza. read more >

Analyst: Biopharma Makes 'Right Call' in Stopping Combination Agent in Trial

Research Report
  ()
A Mackie Research Capital Corp. note reviewed recent and upcoming developments in this immunotherapy developer's clinical study. read more >

Urgent Update on Canadian Health Company Acquisition

Contributed Opinion
  ()
Technical analyst Clive Maund charts the potentially transformative acquisition of a medical software provider in Canada. read more >

15 Reasons Why Hemp Producer Elixinol Should Be in Your Portfolio

Contributed Opinion
  ()
With the U.S. government legalizing hemp in the recently passed 2018 Farm Bill, Fincom Investment Partners profiles a hemp company whose largest market is the U.S. read more >

Small-Cap Firm Announces Major Medical Technology Acquisition

Contributed Opinion
  ()
Ron Struthers of Struthers Resource Stock Report profiles an innovative medical firm in Canada that just announced the acquisition of a medical technology firm, a move that will expand its reach across Canada. read more >

Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate'

Research Report
  ()
A William Blair report reviewed the firm's operational and financial numbers for the period. read more >

Coverage Initiated on Tech Firm Servicing Healthcare Industry

Research Report
  ()
Haywood Securities presented the thesis for investment in this company, including its growth drivers and continued focus on acquisition. read more >

Health Stock 'Looking Set to Bounce Back After 90% Drop'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. read more >

Strong Health Stock 'Ready to Commence New Upleg'

Contributed Opinion
  ()
Technical analyst Clive Maund analyzes a rapidly expanding company with medical clinics in British Columbia that is using advanced technology and AI. read more >

Small-Cap Company Could Be the Face of the Future of Medicine

  ()
A company in Canada that is changing the paradigm for providing healthcare in Canada and potentially elsewhere by integrating technology and artificial intelligence has just announced a major acquisition. read more >

Biotech Delivers Positive Study Results for Prostate Cancer Prognostic Test

Research Report
  ()
An H.C. Wainwright & Co. report reviewed this firm's latest news concerning a data readout, trial approval and therapeutic application. read more >

Precision Medicine Developer Secures Another Patent for Drug Candidate

Research Report
  ()
This company takes a step forward in its efforts to protect its intellectual property. read more >

Biotech to Lead dMAB Tech Field with First Clinically Tested Product

Research Report
  ()
An H.C. Wainwright & Co. report discussed recent articles covering results of this firm's preclinical studies. read more >

Neuromonitoring Stock 'Ready to Rally'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a neuromonitoring company that he believes is undervalued. read more >
News Update

Cannabis Provider to Debut Five More Dispensaries in Florida

News Update
  ()
This company plans to add even more this year as well. read more >

Biopharma Agrees to $215 Million Acquisition Deal

Research Report
  ()
An H.C. Wainwright & Co. report detailed the terms of the definitive agreement concerning the merger. read more >
Showing Results: 1 to 25 of 95 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"DRRX will move its alcoholic hepatitis program to Dr. Craig McClain." ❭
– Patrick Dolezal, LifeSci Capital